Advertisement
News
Subscribe to MDT Magazine News

Boston Scientific Announces FDA Approval of Renegade® HI-FLOâ„¢ Fathom® Pre-Loaded System

January 31, 2011 3:31 am | by Boston Scientific | Comments

New system integrates market-leading Renegade HI-FLO Microcatheter with high-torque Fathom-16 Steerable Guidewire for peripheral embolization procedures

TOPICS:

Functional Technologies Announces First Quarter 2011 Financial Results

January 31, 2011 2:45 am | by The Associated Press | Comments

http://www.functionaltechcorp.com () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the first quarter ended November 30, 2010. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with...

Functional Technologies reports lower Q1 loss as operating expenses lower

January 31, 2011 2:45 am | by The Associated Press | Comments

Functional Technologies Corp. (TSXV:FEB) tightens first-quarter loss of $773,600 compared to $908,900 a year ago, as operating expenses were lowered to $896,700 in the period.

Advertisement

University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology

January 31, 2011 2:34 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., Jan. 31, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial (WIN Trial) to treat leukemia...

TOPICS:

China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011

January 31, 2011 2:33 am | by Bio-Medicine.Org | Comments

BEIJING, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter...

TOPICS:

IBM to Expand U.S. Investment in Entrepreneurs

January 31, 2011 1:32 am | by IBM | Comments

IBM today announced that it will invest $150 million in 2011 to fund programs that promote entrepreneurs and new business opportunities in the United States. The announcement was made as part of the White House-led StartUP America campaign launched today. E-mail this page Save to...

Winner Medical Group Inc. to Host First Quarter 2011 Earnings Conference Call on Thursday, February 10, 2011 at 08:30 a.m. EST

January 31, 2011 1:32 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Jan. 31, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced...

TOPICS:

Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics

January 31, 2011 1:31 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., Jan. 31, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is pleased to announce...

TOPICS:
Advertisement

Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification

January 30, 2011 11:35 pm | by Bio-Medicine.Org | Comments

CHADDS FORD, Pa., Jan. 31, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc.,  have received a Paragraph IV Certification Notice from Mylan Technologies Inc. advising of the filing of an Abbreviated...

TOPICS:

Cadence Makes Big Addition to Pain-Relief Arsenal

January 30, 2011 11:32 pm | by San Diego Business Journal | Comments

Befitting the company's name, San Diego-based Cadence Pharmaceuticals Inc.'s sales staffers are marching to appointments to get a share of the pain-relief business at the nation's hospitals.

TOPICS:

HEALTHY IMPACT

January 30, 2011 10:32 pm | by San Diego Business Journal | Comments

Health care reform may be a permanent fix to provide every American with basic medical services, but look to temporary staffing firms to do a lot of the heavy - and challenging - lifting on the patient care recruitment front.

TOPICS:

Study finds little decline in hepatitis C infections among injection drug users

January 30, 2011 9:33 pm | by EurekAlert | Comments

(Infectious Diseases Society of America) A recent 20-year study of injection drug users in Baltimore found a significant decline in new cases of HIV infection but only a slight decline in new cases of hepatitis C virus (HCV) infection. The findings suggest that efforts to curb...

TOPICS:

Despite China's might, US factories maintain edge

January 30, 2011 7:45 pm | by PAUL WISEMAN - AP Economics Writer - Associated Press | Comments

U.S. factories are closing. American manufacturing jobs are reappearing overseas. China's industrial might is growing each year.And it might seem as if the United States doesn't make world-class goods as well as some other nations."There's no reason Europe or China should have the fastest...

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011

January 30, 2011 1:31 pm | by Bio-Medicine.Org | Comments

DETROIT, Jan. 30, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) generated net sales of $40.4 million and $268.2 million in the third quarter and first nine months of its Fiscal Year 2011, respectively, as compared to $52.0 million and $178.4 million, respectively, for...

TOPICS:

Scripps Research scientists reveal key mechanism governing nicotine addiction

January 30, 2011 9:34 am | by EurekAlert | Comments

(Scripps Research Institute) Scientists from the Florida campus of the Scripps Research Institute have identified a pathway in the brain that regulates an individual's vulnerability to the addictive properties of nicotine. The findings suggest a new target for anti-smoking therapies.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading